Aarkstore - Papillary Thyroid Cancer-Pipeline Insights, 2014 - PowerPoint PPT Presentation

Loading...

PPT – Aarkstore - Papillary Thyroid Cancer-Pipeline Insights, 2014 PowerPoint presentation | free to download - id: 6c0ef1-YjlhM



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Aarkstore - Papillary Thyroid Cancer-Pipeline Insights, 2014

Description:

DelveInsights, Papillary Thyroid Cancer-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Papillary Thyroid Cancer. – PowerPoint PPT presentation

Number of Views:28

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Aarkstore - Papillary Thyroid Cancer-Pipeline Insights, 2014


1
Papillary Thyroid Cancer-Pipeline Insights,
2014
Category Pharmaceuticals Healthcare
  • Browse Complete Report -
  • http//www.aarkstore.com/healthcare/77315/-papilla
    ry-thyroid-cancer-pipeline-insights-2014

2
Summary
  • DelveInsights, Papillary Thyroid Cancer-Pipeline
    Insights, 2014, report provides comprehensive
    insights about pipeline drugs across this
    indication. A key objective of the report is to
    establish the understanding for all the pipeline
    drugs that fall under Papillary Thyroid Cancer.
    This report provides information on the
    therapeutic development based on the Papillary
    Thyroid Cancer dealing with all the pipeline
    drugs, comparative analysis at various stages
    covering Filed, Phase III, Phase II, Phase I, IND
    filed, Preclinical, Discovery and unknown stages,
    therapeutics assessment by monotherapy and
    combination products and molecule type drug
    information. The report also covers the companies
    information involved in the therapeutic
    development of the products. It also has
    highlighted the discontinued and dormant products.

3
Summary
  • Data Sources
  • The report is built using data and information
    sourced from proprietary databases, primary and
    secondary research and in-house analysis by
    DelveInsight team of industry experts.Secondary
    sources information and data has been collected
    from various printable and non-printable sources
    like search engines, News websites, Government
    Websites, Trade Journals, White papers,
    Magazines, Trade associations, Books, Industry
    Portals, Industry Associations and access to
    available databases.Note This report requires
    certain updates. We have all the information
    available but require 3 business days to complete
    the process and ensure it is as up-to-date as
    possible. Certain sections in the report may be
    removed or altered based on the availability and
    relevance of data for the indicated Indication.

4
Summary
  • Scope 
  • The report provides a snapshot of the global
    therapeutic landscape of Papillary Thyroid
    CancerThe report provides pipeline products
    under drug profile section which includes product
    description, MOA, licensors collaborators,
    development partner and chemical
    informationCoverage of the Papillary Thyroid
    Cancer pipeline on the basis of target, MOA,
    route of administration, technology involved and
    molecule typeThe report reviews key players
    involved in the therapeutics development for
    Papillary Thyroid Cancer and also provide company
    profilingThe report also gives the information
    of dormant and discontinued pipeline
    projects Pipeline products coverage based on
    various stages of development ranging from
    preregistration till discovery and undisclosed
    stages Provides pipeline assessment by
    monotherapy and combination therapy products,
    stage of development and molecule type

5
Summary
  • Reasons to buyComplete Pipeline intelligence
    and complete understanding over therapeutics
    development for Papillary Thyroid Cancer
  • Identify the relationship between the drugs and
    use it for target finding, drug repurposing, and
    precision medicine.
  • Devise corrective measures for pipeline projects
    by understanding Papillary Thyroid Cancer
    pipeline depth and focus of Indication
    therapeutics
  • Developing strategic initiatives to support your
    drug development activities.
  • Optimize your portfolio and keep you in touch
    with the rapidly changing pharmaceutical markets,
    and make the best decisions for your business.

6
Summary
  • Develop and design in licensing and out licensing
    strategies by identifying prospective partners
    with the most attractive projects to enhance and
    expand business potential and Scope
  • Provides strategically significant competitor
    information, analysis, and insights to formulate
    effective RD development strategies
  • Modify the therapeutic portfolio by identifying
    discontinued projects and understanding the
    factors that drove them from pipeline
  • Gaining a Full Picture of the Competitive
    Landscape for Evidence based Decisions
  • You can order full Report with TOC and for Sample
    page visit _at_
  • http//www.aarkstore.com/healthcare/77315/-papill
    ary-thyroid-cancer-pipeline-insights-2014

7
Table of Content
  • Papillary Thyroid Cancer OverviewPapillary
    Thyroid Cancer Pipeline TherapeuticsPapillary
    Thyroid Cancer Therapeutics under Development by
    Companies Papillary Thyroid Cancer Late Stage
    Products (Filed and Phase III)Comparative
    Analysis Papillary Thyroid Cancer Mid Clinical
    Stage Products (Phase II)Comparative
    Analysis Papillary Thyroid Cancer Early Clinical
    Stage Products (Phase I and IND
    Filed)Comparative Analysis Papillary Thyroid
    Cancer Discovery and Pre-Clinical Stage
    Products Comparative Analysis 

8
Table of Content
  • Drug Candidate ProfilesPapillary Thyroid Cancer
    Therapeutics Assessment Assessment by
    Monotherapy Products Assessment by Combination
    Products Assessment by Route of
    Administration Assessment by Molecule
    Type Papillary Thyroid Cancer Discontinued
    Products Papillary Thyroid Cancer Dormant
    ProductsCompanies Involved in Therapeutics
    Development for Papillary Thyroid
    Cancer Appendix Methodology Contact
    Us Disclaimer

9
List of Tables
  • Number of Products under Development for
    Papillary Thyroid Cancer, 2014Number of Products
    under Development by Companies Comparative
    Analysis by Late Clinical Stage Products (Filed
    and Phase III), 2014Comparative Analysis Mid
    Clinical Stage Products (Phase II),
    2014Comparative Analysis Early Clinical Stage
    Products (Phase I and IND Filed),
    2014Comparative Analysis Discovery and
    Pre-Clinical Stage Products, 2014Drug Candidates
    ProfilesPapillary Thyroid Cancer Assessment by
    Monotherapy Products Papillary Thyroid Cancer
    Assessment by Combination Products 

10
List of Tables
  • Papillary Thyroid Cancer Assessment by Route of
    Administration Papillary Thyroid Cancer
    Assessment by Stage and Route of
    Administration Papillary Thyroid Cancer
    Assessment by Molecule Type Papillary Thyroid
    Cancer Assessment by Stage and Molecule
    Type Papillary Thyroid Cancer Therapeutics
    Discontinued Products Papillary Thyroid Cancer
    Therapeutics Dormant ProductsProducts under
    Development by Companies, 2014

11
List of Figures
  • Number of Products under Development for
    Papillary Thyroid Cancer, 2014Late Clinical
    Stage Products (Filed and Phase III), 2014Mid
    Clinical Stage Products (Phase II), 2014Early
    Clinical Stage Products (Phase I and IND Filed),
    2014Discovery and Pre-Clinical Stage Products,
    2014Papillary Thyroid Cancer Assessment by
    Monotherapy Products Papillary Thyroid Cancer
    Assessment by Combination Products Papillary
    Thyroid Cancer Assessment by Route of
    Administration Papillary Thyroid Cancer
    Assessment by Stage and Route of
    Administration Papillary Thyroid Cancer
    Assessment by Molecule Type Papillary Thyroid
    Cancer Assessment by Stage and Molecule Type

12
Related Reports
  • 2015 Worldwide Medical Laboratories
    Industry-Industry Market Report
  • 2015 Worldwide Pharmaceutical Preparation Mfg.
    Industry-Industry Market Report
  • OncoPlex Diagnostics - Pharmaceuticals
    Healthcare - Deals and Alliances Profile
  • MetaStat, Inc. - Pharmaceuticals Healthcare -
    Deals and Alliances Profile
  • Advanced Cell Diagnostics, Inc. - Pharmaceuticals
    Healthcare - Deals and Alliances Profile
  • Ascension Health - Pharmaceuticals Healthcare -
    Deals and Alliances Profile
  • Accretive Health, Inc. (ACHI) - Strategic SWOT
    Analysis Review
  • Jazz Pharmaceuticals plc (JAZZ) - Financial and
    Strategic SWOT Analysis Review
  • Pharmstandard (PHST) - Financial and Strategic
    SWOT Analysis Review
  • GLG Life Tech Corporation (GLG) - Financial and
    Strategic SWOT Analysis Review

13
  • Papillary Thyroid Cancer-Pipeline Insights, 2014
  • Published Dec. 2014 60 Pages
  • DelveInsights, Papillary Thyroid Cancer-Pipeline
    Insights, 2014, report provides comprehensive
    insights about pipeline drugs across this
    indication.
    Price

Format Price
PDF 1250
Site Licence 2500
Enterprise Wide Licence 4000
14
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953
  • You Can Visit http//www.aarkstore.com
  • OR Mail us at contact_at_aarkstore.com
  • Blog
  • http//www.aarkstore.com/blog/
  • Conference
  • http//conference.aarkstore.com/
  • News
  • http//www.aarkstore.com/news
About PowerShow.com